| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/18/1994 | WO1994018345A1 Receptor-binding antiproliferative peptides |
| 08/18/1994 | WO1994018332A2 Anthrax toxin fusion proteins and uses thereof |
| 08/18/1994 | WO1994018328A1 Protein kinase c (iota) |
| 08/18/1994 | WO1994018327A1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
| 08/18/1994 | WO1994018326A2 Regulatory gene for clavulanic acid biosynthesis |
| 08/18/1994 | WO1994018325A1 Tnf-alpha muteins and a process for preparing them |
| 08/18/1994 | WO1994018324A2 Phospho-specific antibodies against transcription factors, more specifically against a creb derived peptide |
| 08/18/1994 | WO1994018323A1 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 08/18/1994 | WO1994018322A1 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS |
| 08/18/1994 | WO1994018321A1 GLYCAM-1 (SgP50) VARIANTS |
| 08/18/1994 | WO1994018320A1 Expression of protective antigens |
| 08/18/1994 | WO1994018319A1 Novel polypeptides having serotoninergic receptor activity, nucleic acids coding therefor and use thereof |
| 08/18/1994 | WO1994018318A1 Totally synthetic affinity reagents |
| 08/18/1994 | WO1994018317A1 Regulated transcription of targeted genes and other biological events |
| 08/18/1994 | WO1994018316A2 APOLIPOPROTEIN B mRNA EDITING PROTEIN COMPOSITIONS AND METHODS |
| 08/18/1994 | WO1994018315A1 Use of intra-platelet urokinase-type plasminogen activators for long-term inhibition of thrombosis |
| 08/18/1994 | WO1994018309A1 Novel receptor-type phosphotyrosine phosphatase-gamma |
| 08/18/1994 | WO1994018308A1 Novel receptor-type phosphotyrosine phosphatase-beta |
| 08/18/1994 | WO1994018240A1 Filamentous fungus proteins for binding and transporting lipids, preparation method therefor and use thereof |
| 08/18/1994 | WO1994018239A1 Control of cell proliferation |
| 08/18/1994 | WO1994018235A1 Novel cyclic pentapeptide |
| 08/18/1994 | WO1994018233A1 Thymosin alpha-1 derivatives |
| 08/18/1994 | WO1994018232A1 Methods for generating broadly neutralizing anti-hiv antibodies and antigens capable of eliciting same |
| 08/18/1994 | WO1994018231A1 Inhibition of trauma-induced tumor growth |
| 08/18/1994 | WO1994018230A1 Inhibition of hiv replication by peptide-copper complexes |
| 08/18/1994 | WO1994018229A1 1,2,4-triazinone derivatives and their use in therapy |
| 08/18/1994 | WO1994018228A1 Aqueous protein composition, glycoprotein contained therein, prepration method therefor and uses thereof |
| 08/18/1994 | WO1994018223A1 Detection of conversion to mucoidy in pseudomonas aeruginosa infecting cystic fibrosis patients |
| 08/18/1994 | WO1994017831A1 A combination of neurotrophin and antibody directed toward myelin-associated neurite growth inhibitory protein promotes central nervous system regeneration |
| 08/18/1994 | WO1994017828A2 Treatment for insulin dependent diabetes |
| 08/18/1994 | WO1994017822A1 PULMONARY ADMINISTRATION OF sCR1 AND OTHER COMPLEMENT INHIBITORY PROTEINS |
| 08/18/1994 | WO1994017821A1 Use of thrombine inhibitors for controlling neurodegenerative diseases |
| 08/18/1994 | WO1994017819A1 Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant |
| 08/18/1994 | WO1994017818A1 Methods for treating amyotrophic lateral sclerosis with cntf |
| 08/18/1994 | WO1994017817A1 Inhibitors of thrombosis |
| 08/18/1994 | WO1994017816A1 Role of atp-ubiquitin-dependent proteolysis in mhc-1 restricted antigen presentation and inhibitors thereof |
| 08/18/1994 | WO1994017799A1 Method for treating infertility |
| 08/18/1994 | WO1994017784A1 Pulmonary administration of erythropoietin |
| 08/18/1994 | WO1994017778A1 Method of enhancing hair growth and hair revitalizing compositions comprising lutzomyia protein |
| 08/18/1994 | WO1994017773A2 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
| 08/18/1994 | WO1994014960A3 Protocadherin, their autibodies and uses |
| 08/18/1994 | WO1994011026A3 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 08/18/1994 | WO1994010203A3 Op-3-induced morphogenesis |
| 08/18/1994 | WO1994006454A3 Inhibitiion of retrovirus infection |
| 08/18/1994 | WO1993008259A3 Inhibitors of dipeptidyl-aminopeptidase type IV |
| 08/18/1994 | DE4311580C1 Glycoproteins, process for their preparation and pharmaceutical compositions containing them |
| 08/18/1994 | DE4304731A1 Thrombin inhibitor from the saliva of protostomes |
| 08/18/1994 | CA2155866A1 Method of enhancing hair growth and hair revitalizing compositions comprising lutzomyia protein |
| 08/18/1994 | CA2155725A1 Novel receptor-type phosphotyrosine phosphatase-gamma |
| 08/18/1994 | CA2155646A1 Phospho-specific antibodies against a creb derived peptide |
| 08/18/1994 | CA2155554A1 Role of atp-ubiquitin-dependent proteolysis in mhc-1 restricted antigen presentation and inhibitors thereof |
| 08/18/1994 | CA2155545A1 Novel receptor-type phosphotyrosine phosphatase-beta |
| 08/18/1994 | CA2155540A1 Methods for treating amyotrophic lateral sclerosis with cntf |
| 08/18/1994 | CA2155514A1 Anthrax toxin fusion proteins and uses thereof |
| 08/18/1994 | CA2155413A1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion |
| 08/18/1994 | CA2155120A1 Expression of protective antigens |
| 08/18/1994 | CA2155109A1 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
| 08/18/1994 | CA2155103A1 Tnf-alpha muteins and a process for preparing them |
| 08/18/1994 | CA2154266A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
| 08/18/1994 | CA2153420A1 The use of thrombin inhibitors for controlling neurodegenerative disorders |
| 08/18/1994 | CA2153162A1 New polypeptides having serotoninergic receptor activity, nucleic acids coding therefor and uses thereof |
| 08/18/1994 | CA2133557A1 Inhibition of trauma-induced tumor growth |
| 08/18/1994 | CA2117889A1 A combination of neurotrophin and antibody directed toward myelin-associated neurite growth inhibitory protein promotes central nervous system regeneration |
| 08/18/1994 | CA2115807A1 Purified form of streptogramins, its preparation and pharmaceutical compositions containing same |
| 08/17/1994 | EP0610744A1 Sulfonamide aminomethylene derivatives as immunosuppressants |
| 08/17/1994 | EP0610743A1 Novel aminomethylene-peptides as immunosuppressants |
| 08/17/1994 | EP0610502A1 Emulsion containing parathyroid hormone for pernasal administration |
| 08/17/1994 | EP0610499A1 Proteoglycan(g 009) effective in enhancing antitumor immunity |
| 08/17/1994 | EP0610487A1 New aminoacid derivates, process for producing the same and pharmaceutical compositions containing these compounds |
| 08/17/1994 | EP0610481A1 Extraction of collagen |
| 08/17/1994 | EP0610475A1 Enzymatically-produced dimeric il-2 and a nerve-derived transglutaminase enzyme for its preparation |
| 08/17/1994 | EP0610447A1 CDw52 - SPECIFIC ANTIBODY FOR TREATMENT OF T-CELL MEDIATED INFLAMMATION OF THE JOINTS |
| 08/17/1994 | EP0610446A1 Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid |
| 08/17/1994 | EP0610445A1 Compositions comprising a bactericidal/permeability increasing protein and a lipid carrier, methods of making same, and uses thereof |
| 08/17/1994 | EP0610427A1 TGF-$g(b) TYPE RECEPTOR cDNAS AND USES THEREFOR |
| 08/17/1994 | EP0610420A1 Cell cycle controlling compositions and methods of using same |
| 08/17/1994 | EP0610356A1 Diagnosis and treatment of bacterial dysentery |
| 08/17/1994 | EP0610345A1 Combined cellular and immunosuppressive therapies |
| 08/17/1994 | EP0610336A1 Treatment of neurological conditions by an interleukin-1 inhibiting compound |
| 08/17/1994 | EP0610335A1 Recombitope peptides |
| 08/17/1994 | EP0610322A1 Helicobacter pylori genes necessary for the regulation and maturation of urease, and use thereof |
| 08/17/1994 | EP0610317A1 Inhibitors of dipeptidyl-aminopeptidase type iv |
| 08/17/1994 | EP0610298A1 Preventing allograft rejection with antibodies to adhesion molecules |
| 08/17/1994 | EP0610290A1 Treatment of ocular inflammation by blockage of cell adhesion molecules |
| 08/17/1994 | EP0610286A1 Recombinant immunotoxins |
| 08/17/1994 | EP0610257A1 In vitro antibody perfusion of kidney grafts |
| 08/17/1994 | EP0610254A1 Glial derived neurotrophic factor |
| 08/17/1994 | EP0610246A1 Novel thrombin-inhibiting protein from ticks |
| 08/17/1994 | EP0610201A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 08/17/1994 | EP0563214A4 Bifunctional antibodies and method of preparing same |
| 08/17/1994 | EP0451215B1 Pulmonary administration of pharmaceutically active substances |
| 08/17/1994 | EP0391960B1 Genetic modification of endothelial cells |
| 08/17/1994 | EP0391909B1 Ocular cyclosporin composition |
| 08/17/1994 | EP0305387B1 Insulinotropic hormone |
| 08/17/1994 | EP0248909B1 Anticytomegaloviral human monoclonal antibody and process for its preparation |
| 08/17/1994 | CN1090928A Method for early detection, detection of the severity and for a treatment-accompanying assessment of the course of a sepsis, as well as a means for carrying out said method |
| 08/17/1994 | CN1090776A Method for the safe administration of fatty acids |
| 08/16/1994 | US5338840 DNA encoding glioma-derived growth factor having vascular endothelial cell growth promoting activity |
| 08/16/1994 | US5338836 Biologically active porcine somatotropin polypeptides and methods of using the same |
| 08/16/1994 | US5338835 Mutant forms with unique glycosylation patterns |